Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted Terrain.
JAMA neurology（2023）
摘要
This Viewpoint discusses the findings of the Clarity AD trial, which studied lecanemab for patients with early-stage Alzheimer disease.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要